The residual risk challenge in CVD: How important are triglycerides?

The residual risk challenge in CVD How important are triglycerides
10' education - Sep. 25, 2020 - Prof. Ulf Landmesser, MD
  • Overview

    What is the role of triglyceride-rich lipoproteins in residual risk in patients with ASCVD?

  • Educational information

    This lecture by prof. Ulf Landmesser was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.

  • Faculty

    Prof. Ulf Landmesser, MD, cardiologist, Charité-Universitätsmedizin Berlin, Germany.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from Amarin.

    Click here for the meeting report

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free